Adcock Ingram Holdings Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AIHLF research report →
About the company
Adcock Ingram Holdings Limited operates as a global healthcare enterprise, engaged in the production, promotion, and distribution of a diverse array of medical and wellness products. Its geographical footprint extends across South Africa, North America (including the United States and Canada), the United Kingdom, other European countries, and various international territories. The company's comprehensive product lineup features non-prescription (over-the-counter) medications, prescribed pharmaceuticals, consumer health goods, as well as medical instrumentation and surgical provisions.
- CEO
- Andrew Gideon Hall
- IPO
- 2014
- HQ
- Midrand, ZA
Price Chart
- Market Cap
- $624.32M
- P/E
- 12.79
- P/S
- 1.12
- P/B
- 1.88
- EV/EBITDA
- 7.55
- Div Yield
- 3.74%
- Gross Margin
- 32.99%
- Op Margin
- 11.03%
- Net Margin
- 8.80%
- ROE
- 15.27%
- ROIC
- 12.98%
- Revenue
- $9.76B · 1.22%
- Net Income
- $858.51M · 5.47%
- EPS
- $5.85 · 8.33%
- Op Income
- $1.08B
- FCF YoY
- -68.14%
- 52W High
- $3.50
- 52W Low
- $2.45
- 50D MA
- $3.50
- 200D MA
- $2.88
- Beta
- 0.50
- Avg Volume
- 6
Get TickerSpark's AI analysis on AIHLF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our AIHLF coverage
Recent articles, reports, and earnings notes.
No research on AIHLF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AIHLF report →Similar companies
Peers in the same neighborhood.